|
|
|
|
 Dr Luk John,
Associate Professor, Dept of Pharmacology and Dept of Surgery National University Hospital System, Singapore John Luk received B.Sc.(Hon) at Hong Kong University and doctoral degree in Clinical Microbiology at Karolinska in Stockholm. His postdoctoral fellowship was done at Harvard Medical School in Tim Springer’s lab on cell adhesion molecules. He was assistant professor at Case Western Reserve University and associate professor at Hong Kong University before joining the National University of Singapore, where he leads a cancer pharmacology program with special focus on targeting the oncogenic signalling pathways in liver and stomach cancers. He received fellowships from EMBO, NATO, and Merck, filed 4 US patents on his discoveries and inventions, and published 138 papers including Cell, Nature Genetics, Gastroenterology, and Hepatology. Dr. Luk has mentored 16 PhD students and 8 postdoctoral fellows, and also appointed as honorary professor or advisor at top universities like Harvard, Peking, Nanjing and Fudan.Appearing: Conference Day One: Wednesday, 17 March 2010 14.00 Genomic and Proteomic approaches for cancer biomarker development and target validation Dr Luk John, Associate Professor, Dept of Pharmacology and Dept of Surgery,
National University Hospital System, Singapore |
|
|
|
|
|
Session sponsor:
Exhibitors:
|
asia research institution poster presentation
* For first 20 confirmed poster presentations
|
|
|
|
|
|
|
|
|
